#hematopoietic stem cells — Thursday, April 02, 2026 (2 items)
| 0 | 💬 0 |
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.
(nejm.org)
|
New England Journal of Medicine 2026-04-02 | #crispr #genome editing #cell therapy #sickle cell disease #hematopoietic stem cells | |
| 0 | 💬 0 |
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat beta-Thalassemia.
(nejm.org)
|
New England Journal of Medicine 2026-04-02 | #crispr #genome editing #hematopoietic stem cells #hemoglobin #thalassemia |